Bloom Science Inc

Bloom Science Inc. is a clinical-stage biotechnology company headquartered in San Diego, California. The company employs 13 individuals and generates revenue exceeding $10,000. Bloom Science focuses on developing novel therapeutics for patients with rare and complex neurological disorders. Their proprietary IrisRx™ platform utilizes the Gut-Brain Axis to design drugs targeting novel biology with improved safety profiles. This platform leverages the potential of gut commensal microbes to create multi-functional therapeutics and employs a proprietary knowledge base to advance synthetic biology-based candidates. Bloom Science's research pipeline encompasses programs for Dravet syndrome, other rare epilepsies, Amyotrophic Lateral Sclerosis (ALS), neurodegenerative disorders, and cognitive disorders. Bloom Science differentiates itself through its values-driven culture, where team members are empowered to prioritize patient well-being in every clinical trial. Leaders actively engage with the team, driving scientific advancement and pursuing transformative approaches to medicine. For more information about Bloom Science, visit bloomscience.com/.